Balabhadrapatruni V S K Chakravarthi
Overview
Explore the profile of Balabhadrapatruni V S K Chakravarthi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
4703
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Qiao Y, Asangani I, Ateeq B, Poliakov A, Cieslik M, et al.
Cancer Cell
. 2024 Aug;
42(8):1471.
PMID: 39137731
No abstract available.
2.
Agarwal S, Behring M, Kim H, Bajpai P, Chakravarthi B, Gupta N, et al.
Transl Oncol
. 2021 Sep;
14(11):101142.
PMID: 34538338
No abstract available.
3.
Robinson A, Chakravarthi B, Agarwal S, Chandrashekar D, Davenport M, Chen G, et al.
Transl Oncol
. 2021 May;
14(8):101128.
PMID: 34049151
Lung cancer is the leading cause of cancer-related deaths globally and is histologically defined as either small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC), with the latter...
4.
Chakravarthi B, Singh S, Kamalraj S, Gupta V, Jayabaskaran C
Sci Rep
. 2020 Dec;
10(1):21139.
PMID: 33273486
Taxol (paclitaxel), a plant-derived anticancer drug, has been among the most successful anticancer drugs of natural origin. Endophytic fungi have been proposed as a prominent alternative source for Taxol and...
5.
Agarwal S, Behring M, Kim H, Chandrashekar D, Chakravarthi B, Gupta N, et al.
Mol Oncol
. 2020 Oct;
14(12):3007-3029.
PMID: 33037736
Overexpression of TRIP13, a member of the AAA-ATPase family, is linked with various cancers, but its role in metastasis is unknown in colorectal cancer (CRC). In the current study, we...
6.
Agarwal S, Chakravarthi B, Kim H, Gupta N, Hale K, Balasubramanya S, et al.
Transl Oncol
. 2020 May;
13(7):100776.
PMID: 32422575
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with an extremely poor prognosis. There is an urgent need to identify new therapeutic targets and also understand the mechanism of PDAC...
7.
Chandrashekar D, Chakravarthi B, Robinson A, Anderson J, Agarwal S, Balasubramanya S, et al.
Oncogene
. 2020 Apr;
39(20):4077-4091.
PMID: 32231273
Muscle-invasive bladder carcinomas (MIBCs) are aggressive genitourinary malignancies. Metastatic urothelial carcinoma of the bladder is generally incurable by current chemotherapy and leads to early mortality. Recent studies have identified molecular...
8.
Agarwal S, Chakravarthi B, Behring M, Kim H, Chandrashekar D, Gupta N, et al.
Cancers (Basel)
. 2020 Mar;
12(4).
PMID: 32218208
The identification of colorectal cancer (CRC) molecular targets is needed for the development of drugs that improve patient survival. We investigated the functional role of phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase...
9.
Agarwal S, Behring M, Kim H, Bajpai P, Chakravarthi B, Gupta N, et al.
Transl Oncol
. 2020 Mar;
13(4):100754.
PMID: 32199274
Deposition, remodeling, and signaling of the extracellular matrix facilitate tumor growth and metastasis. Here, we demonstrated that an enzyme, collagen prolyl 4-hydroxylase, alpha polypeptide I (P4HA1), which is involved in...
10.
Nam H, Kundu A, Brinkley G, Chandrashekar D, Kirkman R, Chakravarthi B, et al.
Matrix Biol
. 2020 Jan;
89:43-58.
PMID: 31982456
The transcriptional events that promote invasive and metastatic phenotypes in renal cell carcinoma (RCC) remain poorly understood. Here we report that the decreased expression of peroxisome proliferator-activated receptor gamma, coactivator...